Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $52.96 ($2.1M) on 2018-10-19, disclosed to the SEC on 2018-10-19.
Scheduled sale ($2.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.23 | 13,136 | $712K | 33.1% |
| 2 | $54.36 | 718 | $39K | 1.8% |
| 3 | $55.13 | 5,364 | $296K | 13.8% |
| 4 | $55.29 | 200 | $11K | 0.5% |
| 5 | $55.90 | 400 | $22K | 1.0% |
| 6 | $52.96 | 6,100 |
| $323K |
| 15.0% |
| 7 | $53.20 | 618 | $33K | 1.5% |
| 8 | $53.74 | 6,300 | $339K | 15.8% |
| 9 | $54.69 | 300 | $16K | 0.8% |
| 10 | $54.78 | 4,700 | $257K | 12.0% |
| 11 | $55.57 | 1,800 | $100K | 4.7% |
| Total | $54.22 avg | 39,636 | $2.1M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |